EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of Coronary Sinus Reducer on Angina Symptoms in Patients With Myocardial Ischemia Without Obstructive Coronary Artery Disease

Francesco Giannini iD, Francesco Ponticelli iD, Maayan Konigstein, Stefan Verheye iD, Carlo Zivelonghi iD, Pierfrancesco Agostoni iD, Alessandro Cafaro iD, Tiffany Patterson, Simon Redwood, Kevin Cheng, Ranil De Silva, Alfonso Ielasi und 6 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70072 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Francesco Giannini und 17 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Cardiology Unit, IRCCS Galeazzi Sant'Ambrogio Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Coronary Sinus, Angina Pectoris, Cardiac Catheterization, Myocardial Ischemia. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronary sinus (CS) Reducer implantation shows favorable results in alleviating angina symptoms in patients with obstructive coronary artery disease (CAD) with non‐revascularizable lesions. Whether CS Reducer is effective also in patients without obstructive epicardial CAD remains unsettled.

Aims

We sought to assess the potential benefits of the CS narrowing in patients without obstructive presenting with refractory angina.

Methods

Consecutive refractory angina patients, with objective evidence of myocardial ischemia despite optimal medical therapy (OMT), who underwent CS Reducer implantation, were enrolled in an international registry. Study cohort was divided into two groups: patients with non‐obstructive CAD (< 50% narrowing in all epicardial coronary arteries or a negative intracoronary fractional flow reserve test in case of intermediate lesions), and patients with obstructive CAD. The study outcome was the improvement of the Canadian Cardiovascular Society (CCS) angina score at 12‐month follow‐up in both groups of patients.

Results

Of 285 enrolled patients with successful CS Reducer implantation, 46 patients (16%) had non‐obstructive CAD and 239 patients (84%) had obstructive CAD. Baseline CCS angina score was similar in both groups (2.9 ± 0.5 vs. 2.9 ± 0.6, p = 0.884). At 12‐month follow‐up, the improvement in CCS angina score was similar in both groups (−1.4 ± 0.8 vs. −1.3 ± 0.9 vs. p = 0.67). Both groups had the same CCS angina score at 12‐month follow‐up (1.6 ± 0.8 p = 0.80). Improvement of ≥ 2 CCS classes were 41.9% and 45.1% in patients with non‐obstructive and obstructive CAD, respectively, p = 0.6746.

Conclusions

In patients with refractory angina and myocardial ischemia, CS Reducer implantation improves angina symptoms in patients with myocardial ischemia with and without obstructive CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary SinusAngina PectorisCardiac CatheterizationMyocardial IschemiaCoronary Artery DiseaseHumansMaleFemaleMiddle AgedTreatment OutcomeAgedRegistriesTime FactorsCoronary AngiographyProsthesis DesignFractional Flow Reserve, Myocardial

Stichwörter der Autor:innen

coronary sinus reducernon‐obstructive coronary artery diseaserefractory angina

Autor:innen und Institutionen

  • Interventional Cardiology Unit, IRCCS Galeazzi Sant'Ambrogio Hospital, Milan, Italy.
  • Humanitas University, Milan, Italy.
  • Division of Cardiology, Tel Aviv Sourasky Medical Center, and the Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Antwerp Cardiovascular center, Ziekenhuis Netwerk Antwerpen Middlheim, Antwerp, Belgium.
  • Department of Cardiology, General Hospital "F. Miulli", Acquaviva delle Fonti, Bari, Italy.
  • Cardiothoracic Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

ORCID-Profile: Francesco Giannini, Francesco Ponticelli, Stefan Verheye, Carlo Zivelonghi, Pierfrancesco Agostoni, Alessandro Cafaro, Michele Di Mauro, Clement Servoz

Zitieren

APA

Giannini, F., Ponticelli, F., Konigstein, M., Verheye, S., Zivelonghi, C., Agostoni, P., Cafaro, A., Patterson, T., Redwood, S., Cheng, K., De Silva, R., Ielasi, A., Ioanes, D., Bunc, M., Guarracini, S., Di Mauro, M., Servoz, C., & Banai, S. (2025). Impact of Coronary Sinus Reducer on Angina Symptoms in Patients With Myocardial Ischemia Without Obstructive Coronary Artery Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70072

Vancouver

Giannini F, Ponticelli F, Konigstein M, Verheye S, Zivelonghi C, Agostoni P, et al. Impact of Coronary Sinus Reducer on Angina Symptoms in Patients With Myocardial Ischemia Without Obstructive Coronary Artery Disease. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70072

BibTeX
@article{Giannini2025,
  author = {Giannini, Francesco and Ponticelli, Francesco and Konigstein, Maayan and Verheye, Stefan and Zivelonghi, Carlo and Agostoni, Pierfrancesco and Cafaro, Alessandro and Patterson, Tiffany and Redwood, Simon and Cheng, Kevin and De Silva, Ranil and Ielasi, Alfonso and Ioanes, Dan and Bunc, Matjaž and Guarracini, Stefano and Di Mauro, Michele and Servoz, Clement and Banai, Shmuel},
  title = {Impact of Coronary Sinus Reducer on Angina Symptoms in Patients With Myocardial Ischemia Without Obstructive Coronary Artery Disease},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70072}
}
Kostenlos starten →